Lv41
493 积分 2022-01-14 加入
Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical Trial
3小时前
待确认
Clinical Efficacy of Combined Internal and External Fixation with Nanosilver Dressing and Vacuum Closure for Gustilo Type I/II Open Tibial Fractures
7天前
已关闭
The incidence of surgical site infections in China
8天前
已完结
Surgical site infection
8天前
已关闭
骨科手术部位感染创面预防与治疗的专家共识（2026版）
8天前
已完结
骨科手术部位感染创面预防与治疗的专家共识（2026版）
8天前
已关闭
Do modern therapies change natural history of Neuromyelitis optica?
15天前
已完结
The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese
15天前
已完结
皖公网安备34019202002308
